The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Potential Role of Increased Iron Stores in Diabetes
Abstract
Diabetes mellitus (DM) is an important risk factor for the development of cardiovascular disease. Extensive clinical, epidemiologic, and basic studies suggest that excessive tissue iron stores may contribute to the occurrence and complications of DM. Secondary diabetes occurs in inherited pathologic iron overload syndromes of European- and African-derived populations and is an established complication of transfusional iron overload. Epidemiologic studies have repeatedly shown positive correlation between levels of serum ferritin and those of fasting glucose, insulin, and glycosylated hemoglobin. Iron reduction therapy in hereditary hemochromatosis and transfusional iron overload is associated with improved glucose tolerance and reduced incidence of secondary diabetes. Trials of iron reduction therapy in diabetes mellitus, although limited and inconclusive, have shown clinical improvement in some patients. The current article reviews evidence suggesting that tissue iron contributes to DM and its complications and presents preliminary data that emphasize the potential importance of iron overload in DM of African Americans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Iron 'excess' is also a known feature of gestational diabetes [591-593], and is a clear risk factor for the disease even in 'normal' populations [594-603], and indeed diabetes is a classical consequence of iron overloading as seen in hereditary haemochromatosis [604].”
Citations
Cites
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,791
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,765
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Oxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,921
Pathophysiology of insulin resistance in human disease
Reaven, G. M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.473 · Cited by 1,226
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
Williams, S. B., Cusco, J. A., Roddy, M.-A., Johnstone, M. T., & Creager, M. A. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00522-6 · Cited by 1,014
Research works printed but not linked: 1
- Brittenham, 1996, Iron physiology and iron overload, Blood, 177
Cited by
Sorted by citations
Kell, D. B., & Pretorius, E. (2014) · Metallomics · doi:10.1039/c3mt00347g · Cited by 667
Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women
Jiang, R. (2004) · JAMA · doi:10.1001/jama.291.6.711 · Cited by 598
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“disease even in 'normal' populations [594-603], and”
Simcox, J. A., & McClain, D. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.007 · Cited by 545
“…or both have emerged from studies of other populations, including Europeans and African Americans (Jiang et al., 2004; Tuomainen et al., 1997; Wilson et al., 2003), and from other conditions, including gestational diabetes (Afkhami-Ardekani and Rashidi, 2009) and prediabetes (Sharifi et al.,…”
BackgroundPotential health hazards of eating red meat
Wolk, A. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12543 · Cited by 558
Serum Ferritin and Risk of the Metabolic Syndrome in U.S. Adults
Jehn, M., Clark, J. M., & Guallar, E. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2422 · Cited by 443
“Iron overload may contribute to insulin resistance through mechanisms related to both reduced extraction of insulin and impaired insulin secretion (25).”
BackgroundThe Role of Iron in Diabetes and Its Complications
Swaminathan, S., Fonseca, V. A., Alam, M. G., & Shah, S. V. (2007) · Diabetes Care · doi:10.2337/dc06-2625 · Cited by 423
“15), though no correlation has been found between transferrin saturation and glycemic status (32).”
BackgroundThe role of iron in type 2 diabetes in humans
Rajpathak, S. N., Crandall, J. P., Wylie-Rosett, J., Kabat, G. C., Rohan, T. E., & Hu, F. B. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.005 · Cited by 363
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…2006f; Lim et al. 2001; Rayman et al. 2002; Rouault 2006; Salonen et al. 1992; Sheth and Brittenham 2000; Tuomainen et al. 1998; Valenti et al. 2007; Wilson et al. 2003; You et al. 2003; You and Wang 2005) (Adam- kiewicz et al. 2009; Baune et al. 2010; Busca et al. 2010; DePalma et al. 2010;…”
BackgroundPRIMARY PREVENTION OF DIABETES: What Can Be Done and How Much Can Be Prevented?
Schulze, M. B., & Hu, F. B. (2004) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.26.021304.144532 · Cited by 340
Forouhi, N. G., Harding, A.-H., Allison, M., Sandhu, M. S., Welch, A. A., Luben, R., Bingham, S. A., Khaw, K., & Wareham, N. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0604-5 · Cited by 269
“In addition, iron accumulation in hepatocytes may interfere with the insulin-extracting capacity of the liver [25], and affect insulin synthesis and secretion in the pancreas [26].”
BackgroundZhao, Z., Li, S., Liu, G., Yan, F., Ma, X., Huang, Z., & Tian, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041641 · Cited by 227
“Researchers hypothesized that increased iron deposition in tissues initially induces insulin resistance, and the resulting hyperinsulinemia ultimately causes pancreatic islet apoptosis and the progression of T2D [48].”
BackgroundRNA modifications by oxidation: A novel disease mechanism?
Poulsen, H. E., Specht, E., Broedbaek, K., Henriksen, T., Ellervik, C., Mandrup-Poulsen, T. R., Tonnesen, M., Nielsen, P. E., Andersen, H. U., & Weimann, A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.009 · Cited by 219
“[136] Wilson, J.”
BackgroundHooda, J., Shah, A. N., & Li, Z. (2014) · Nutrients · doi:10.3390/nu6031080 · Cited by 222
“Additionally, excessive heme intake leads to deposition of iron deposition in pancreatic beta cells and other tissues, which induces insulin resistance [91,92].”
BackgroundSchienkiewitz, A., Schulze, M. B., Hoffmann, K., Kroke, A., & Boeing, H. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.2.427 · Cited by 187
“In addition, iron accumulation in hepatocytes may interfere with the insulin-extracting capacity of the liver, while iron accumulation also interferes with insulin synthesis and secretion in the pancreas [2].”
InfluentialZheng, Y., Li, X.-K., Wang, Y., & Cai, L. (2008) · Hemoglobin · doi:10.1080/03630260701727077 · Cited by 181
Kim, Y., Keogh, J., & Clifton, P. (2015) · Metabolism · doi:10.1016/j.metabol.2015.03.008 · Cited by 181
“the relationship between iron and the development of T2DM can be explained by both increased hepatic glucose output and decreased glucose disposal while iron deposition in the pancreatic β-cells leads to impaired insulin secretion [87].”
BackgroundMcClain, D. A., Abraham, D., Rogers, J., Brady, R., Gault, P. M., Ajioka, R. S., & Kushner, J. P. (2006) · Diabetologia · doi:10.1007/s00125-006-0200-0 · Cited by 178
“have higher than average iron indices [38–40].”
Cooksey, R. C., Jones, D., Gabrielsen, S., Huang, J., Simcox, J., Luo, B., Soesanto, Y., Rienhoff, H. Y., Abel, E. D., & McClain, D. A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00022.2010 · Cited by 168
“Similar relationships between iron and diabetes risk are seen in several other populations, including Europeans, African-Americans, gestational diabetics, prediabetics, and individuals with transfusional iron overload (2, 22, 26, 34, 35, 37).”
Kim, B., Ahn, S. H., Bae, S. J., Kim, E. H., Lee, S., Kim, H., Choe, J. W., Koh, J., & Kim, G. S. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1692 · Cited by 172
“Therefore, it has been hypothesized that the formation of hydroxyl radicals catalyzed by iron can contribute to the pathogenesis of various diseases, such as insulin resistance.((25))”
BackgroundVariation in Macro and Trace Elements in Progression of Type 2 Diabetes
Siddiqui, K., Bawazeer, N. M., & Joy, S. S. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/461591 · Cited by 166
“Iron Elevated iron stores may induce diabetes through a variety of mechanisms, including oxidative damage to pancreatic β cells, impairment of hepatic insulin extraction by the liver, and interference with insulin’s ability to suppress hepatic glucose production [31, 32].”
BackgroundKunutsor, S. K., Apekey, T. A., Walley, J. D., & Kain, K. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2394 · Cited by 158
“insulin to suppress glucose production by the liver [46,47].”
BackgroundMetabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin
González, A. S., Bellido, D., Soto, M. B., Pértega-Díaz, S., Olmos, M. Á. M., & Vidal, O. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602384 · Cited by 158
“It is known that increased accumulation of iron affects insulin synthesis and secretion in the pancreas (Wilson et al., 2003) and interferes with the insulin-extracting capacity of the liver (Niederau et al., 1984), thereby leading to peripheral hyperinsulinaemia and impaired insulin secretion;…”
Iron Intake and the Risk of Type 2 Diabetes in Women
Rajpathak, S. N., Ma, J., Manson, J. E., Willett, W. C., & Hu, F. B. (2006) · Diabetes Care · doi:10.2337/dc06-0119 · Cited by 151
“Another potential mechanism is direct iron deposition in the pancreatic -cells that can impair insulin secretion (48).”
BackgroundRole of Iron Deficiency and Overload in the Pathogenesis of Diabetes and Diabetic Complications
Liu, Q., Sun, L. T., Tan, Y., Wang, G., Lin, X., & Cai, L. (2008) · Current Medicinal Chemistry · doi:10.2174/092986709787002862 · Cited by 152
“To control and balance the production of ROSs and RNSs, the cell builds up a set of antioxidants and detoxifying enzymes such as superoxide dismutase, catalase, and glutathione peroxidase that can scavenge excessive ROSs or RNSs.”
BackgroundInfluentialIron metabolism and type 2 diabetes mellitus: A meta‐analysis and systematic review
Liu, J., Li, Q., Yang, Y., & Ma, L. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13216 · Cited by 159
Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases
Pretorius, E., & Kell, D. B. (2014) · Integrative Biology · doi:10.1039/c4ib00025k · Cited by 141
Iron: the hard player in diabetes pathophysiology
Hansen, J. B., Moen, I. W., & Mandrup-Poulsen, T. R. (2014) · Acta Physiologica · doi:10.1111/apha.12256 · Cited by 146
“Whether reducing serum iron by chelation can prevent or delay the development of diabetes has been questioned in an earlier review (Wilson et al. 2003).”
BackgroundJehn, M. L., Guallar, E., Clark, J. M., Couper, D., Duncan, B. B., Ballantyne, C. M., Hoogeveen, R. C., Harris, Z. L., & Pankow, J. S. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwk093 · Cited by 136
“Iron overload may induce insulin resistance by reducing insulin extraction in the liver (20–23) or by reducing insulin synthesis and excretion by the pancreatic beta cells (4, 24).”
BackgroundMontonen, J., Boeing, H., Steffen, A., Lehmann, R., Fritsche, A., Joost, H.-G., Schulze, M. B., & Pischon, T. (2012) · Diabetologia · doi:10.1007/s00125-012-2633-y · Cited by 124
“In addition, iron accumulation in hepatocytes may interfere with the insulin-extracting capacity of the liver, while iron accumulation also interferes with insulin synthesis and secretion in the pancreas [2].”
BackgroundInfluentialChen, X., Scholl, T. O., & Stein, T. P. (2006) · Diabetes Care · doi:10.2337/dc06-0164 · Cited by 122
“There is an extensive body of data suggesting that higher iron stores are associated with risk of type 2 diabetes in nonpregnant subjects (10,12,13,27,28).”
BackgroundHereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Swinkels, D. W., Janssen, M. C. H., Bergmans, J., & Marx, J. J. M. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068684 · Cited by 117
Gestational Diabetes Mellitus in Relation to Maternal Dietary Heme Iron and Nonheme Iron Intake
Qiu, C., Zhang, C., Gelaye, B., Enquobahrie, D. A., Frederick, I. O., & Williams, M. A. (2011) · Diabetes Care · doi:10.2337/dc11-0135 · Cited by 115
“First, increased accumulation of iron affects insulin synthesis and secretion in the pancreas and interferes with the insulinextracting capacity of the liver so that hepatic neoglucogenesis suppression might be implicated (23).”
BackgroundIron deficiency as energetic insult to skeletal muscle in chronic diseases
Dzięgała, M., Josiak, K., Kasztura, M., Kobak, K. A., von Haehling, S., Banasiak, W., Anker, S. D., Ponikowski, P. P., & Jankowska, E. A. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12314 · Cited by 114
NAFLD and hyperinsulinemia are major determinants of serum ferritin levels
Zelber‐Sagi, S., Nitzan, D., Halpern, Z., & Oren, R. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.018 · Cited by 108
“Iron overload may contribute to insulin resistance through mechanisms related to reduced hepatic insulin extraction, resulting in hyperinsulinemia [38,39].”
BackgroundLee, B.-K., Kim, Y., & Kim, Y.-I. (2011) · Metabolism · doi:10.1016/j.metabol.2011.02.008 · Cited by 105
“It has additionally been suggested that iron deposition in pancreatic β-cells impairs insulin secretion in more advanced states of iron overload [40].”
BackgroundInfluentialAn, J., Su, J., Sun, G.-Y., Wang, Q., Fan, Y., Jiang, N., Yang, Y., & Shi, Y. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03442-7 · Cited by 110
Association of iron indices and type 2 diabetes: a meta‐analysis of observational studies
Orban, E., Schwab, S., Thorand, B., & Huth, C. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2506 · Cited by 92
“Its serum concentration is proportional to the total iron binding capacity [14].”
BackgroundAssociation of Serum Ferritin and the Development of Metabolic Syndrome in Middle-Aged Korean Men
Park, S. K., Ryoo, J., Kim, M. G., & Shin, J. (2012) · Diabetes Care · doi:10.2337/dc12-0543 · Cited by 88
“Under oxidative stress, elevated serum ferritinmay contribute to cellular or tissue damage leading to insulin dysfunction, such as insulin resistance and abnormal pancreatic b-cell function, through iron toxicity (23,24).”
BackgroundSuliburska, J., Bogdański, P., Pupek‐Musialik, D., & Krejpcio, Z. (2010) · Biological Trace Element Research · doi:10.1007/s12011-010-8650-0 · Cited by 89
“Studies have already shown that iron overload may contribute to insulin resistance through reduced extraction of insulin and impaired insulin secretion [39].”
Pretorius, E., Bester, J., Vermeulen, N., Alummoottil, S., Soma, P., Buys, A. V., & Kell, D. B. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0192-5 · Cited by 89
“Iron (increased serum ferritin levels) [64-89].”
Biomarkers of body iron stores and risk of developing type 2 diabetes
Rajpathak, S. N., Wylie‐Rosett, J., Gunter, M. J., Negassa, A., Kabat, G. C., Rohan, T. E., & Crandall, J. P. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00985.x · Cited by 85
Acton, R. T., Barton, J. C., Passmore, L. V., Adams, P. C., Speechley, M. R., Dawkins, F. W., Sholinsky, P. D., Reboussin, D. M., McLaren, G. D., Harris, E. L., et al. (2006) · Diabetes Care · doi:10.2337/dc05-1592 · Cited by 88
Kim, B., Lee, S. H., Koh, J., & Kim, G. S. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2363-0 · Cited by 79
“Therefore, increasing iron stores can contribute to the pathogenesis of various diseases, such as insulin resistance [3].”
BackgroundJiang, L., Wang, K., Lo, K. K.-H., Zhong, Y., Yang, A., Fang, X., Akezhuoli, H., Song, Z., Chen, L., An, P., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00495 · Cited by 76
Sun, L., Zong, G., Pan, A., Ye, X., Li, H., Yu, Z., Zhao, Y., Zou, S., Yu, D., Jin, Q., et al. (2013) · Journal of Nutrition · doi:10.3945/jn.113.177808 · Cited by 74
“Indeed, excess iron deposition in pancreatic b cells could impair insulin synthesis and secretion (42,43).”
BackgroundIron supplementation and gestational diabetes in midpregnancy
Bo, S., Menato, G., Villois, P., Gambino, R., Cassader, M., Cotrino, I., & Cavallo‐Perin, P. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.04.049 · Cited by 79
Perna, S., Peroni, G., Faliva, M. A., Bartolo, A., Naso, M., Miccono, A., & Rondanelli, M. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0701-8 · Cited by 76
Lee, D., Jacobs, D. R., Gross, M., & Steffes, M. W. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.045872 · Cited by 68
“It is well known that substantial oxidative stress exists in diabetes (32, 33) and hypertension (34, 35).”
BackgroundPretorius, E., Bester, J., Vermeulen, N., Lipiński, B., Gericke, G. S., & Kell, D. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085271 · Cited by 68
“We have also seen that in diabetes (where iron overload is sometimes also present - and these diseases may be mutually causative [2,13,51,59–65]) RBCs are elongated and twist around fibrin fibers [66].”
BackgroundChoi, K. M., Lee, K. W., Kim, H. Y., Seo, J. A., Kim, S. G., Kim, N. H., Choi, D. S., & Baik, S. H. (2005) · Metabolism · doi:10.1016/j.metabol.2005.05.018 · Cited by 62
“[23].”
Effect of iron overload on glucose metabolism in patients with hereditary hemochromatosis
Hatunic, M., Finucane, F. M., Brennan, A., Norris, S., Pacini, G., & Nolan, J. J. (2009) · Metabolism · doi:10.1016/j.metabol.2009.08.006 · Cited by 56
“Taken together, these findings suggest that iron excess may contribute both to insulin resistance and to decreased insulin secretion [34].”
BackgroundKang, H., Linton, J. A., & Shim, J. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.12.011 · Cited by 56
Iron Withholding: A Defense Against Disease
Weinberg, E. D., & Miklossy, J. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13409 · Cited by 53
“At least one-third of patients with type 2 diabetes have elevated serum ferritin [145].”
InfluentialSoubasi, V., Petridou, S., Sarafidis, K., Tsantali, C. H., Diamanti, E., Buonocore, G., & Drossou-Agakidou, V. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.06.010 · Cited by 54
Jung, C. H., Lee, M. J., Hwang, J. Y., Jang, J. E., Leem, J., Park, J., Lee, J.-B., Kim, H., & Lee, W. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075250 · Cited by 51
“In addition, iron excess probably contributes initially to insulin resistance and subsequently to decreased insulin secretion [37].”
BackgroundMattei, J., Noel, S. E., & Tucker, K. L. (2011) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2011.07.006 · Cited by 50
“Also, because iron overload s correlated with higher HbA1c (30), the potential mediting effect of iron intake, through higher meat consumpion, on this parameter should be considered.”
BackgroundLiang, Y., Gong, Y., Zhang, X., Yang, D., Zhao, D., Quan, L., Zhou, R., Bao, W., & Cheng, G. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00596 · Cited by 49
“An overload of iron can cause insulin resistance leading to increase in the production of hepatic glucose (45, 46), subsequently reducing the secretion of insulin (47).”
BackgroundIron at the Interface of Hepatocellular Carcinoma
Paganoni, R., Lechel, A., & Spasić, M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084097 · Cited by 48
Mitchell, T. C., & McClain, D. A. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0488-y · Cited by 40
Guo, L., Jiang, F., Tang, Y., Si, M., & Jiao, X. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0181 · Cited by 38
“In addition, iron overload may contribute initially to insulin resistance and subsequently to decreased insulin secretion and ultimately result in diabetes.(18) This is confirmed by the evidence of reduced hyperinsulinemia in the presence of iron depletion.”
BackgroundKim, T. H., Hwang, H., & Kim, S.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090105 · Cited by 39
“Under oxidative stress, elevated serum ferritin may promote abnormal insulin secretion by pancreatic b-cells and impairment of insulin extraction by the liver [17,18].”
BackgroundIron Overload Protects from Obesity by Ferroptosis
Wan, M., Jia, L., Xiong, Q., & Du, H. (2021) · Foods · doi:10.3390/foods10081787 · Cited by 36
“Moreover, the insulin receptor is a critical component of insulin signal transduction, and its malfunction is thought to be the fundamental cause of T2DM [17].”
BackgroundInfluentialElsammak, M., Refai, W., Elsawaf, A., Abdel-Fattah, I., Elatti, E. A., & Ghazal, A. A. E. R. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x38141 · Cited by 35
Diabetes mellitus concurrent with hepatic haemosiderosis in two macaws (Ara severa, Ara militaris)
Gancz, A. Y., Wellehan, J. F. X., Boutette, J., Malka, S., Lee, S. E., Smith, D. A., & Taylor, M. (2007) · Avian Pathology · doi:10.1080/03079450701466093 · Cited by 35
“In humans, EIS is strongly associated with DM (Wilson et al., 2003; Platis et al., 2004).”
BackgroundÖzçelik, D., Tunçdemi̇r, M., Öztürk, M., & Uzun, H. (2011) · General Physiology and Biophysics · doi:10.4149/gpb_2011_04_356 · Cited by 34
Basiri, R., Seidu, B., & Cheskin, L. J. (2023) · Nutrients · doi:10.3390/nu15183929 · Cited by 34
“Excessive iron intake has consistently been found to increase ferritin, insulin resistance, and glycosylated hemoglobin, and may also increase diabetes complications [186].”
BackgroundLecube, A., Hernández, C., & Simó, R. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.972 · Cited by 33
Gastrointestinal Complications of Diabetes Mellitus
Ebert, E. C. (2005) · Disease-a-Month · doi:10.1016/j.disamonth.2005.11.002 · Cited by 33
Hatunic, M., Finucane, F. M., Norris, S., Pacini, G., & Nolan, J. J. (2010) · Metabolism · doi:10.1016/j.metabol.2010.06.005 · Cited by 33
“Studies have shown that iron deposition in muscle decreases glucose uptake because of muscle damage and affects insulin synthesis and secretion in the pancreas [30].”
BackgroundActive-Site Environment of Copper-Bound Human Amylin Relevant to Type 2 Diabetes
Seal, M., & Dey, S. G. (2017) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.7b02266 · Cited by 32
Mineral Elements Content of Selected Kenyan Antidiabetic Medicinal Plants
Arika, W. M., & Ogola, P. E. (2015) · Advanced Techniques in Biology & Medicine · doi:10.4172/2379-1764.1000160 · Cited by 31
“Iron interferes with insulin inhibition of glucose production by the liver [35].”
BackgroundDekker, L. H., Nicolaou, M., van der A, D. L., Busschers, W. B., Brewster, L. M., Snijder, M. B., Stronks, K., & van Valkengoed, I. G. M. (2012) · Diabetes Care · doi:10.2337/dc12-1243 · Cited by 30
Jeon, Y. J., Jung, I. A., Kim, S. H., Cho, W. K., Jeong, S. H., Cho, K. S., Park, S. H., Jung, M. H., & Suh, B. (2013) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2013.18.3.141 · Cited by 30
Hämäläinen, P., Saltevo, J. T., Kautiainen, H., Mäntyselkä, P. T., & Vanhala, M. J. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-114 · Cited by 29
“Elevated body iron stores could promote oxidative stress, and in this manner affect the pathogenesis of insulin resistance [4-6].”
BackgroundMetabolic syndrome: A review of emerging markers and management
Singh, B. K., Arora, S., Goswami, B., & Mallika, V. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2009.04.012 · Cited by 29
Relationship between Serum Ferritin Levels and Dyslipidemia in Korean Adolescents
Kim, Y., Kim, D., Roh, Y. K., Ju, S.-Y., Yoon, Y.-J., Nam, G. E., Nam, H.-Y., Choi, J.-S., Lee, J.-E., Sang, J.-E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153167 · Cited by 29
“In addition, iron is a transition metal capable of causing oxidative stress-induced tissue damage by catalyzing the conversion of hydrogen peroxide to free radicals that attack cellular membranes, proteins, and DNA [1,8,12,33], leading to derangements in glucose homeostasis such as insulin resistance and pancreatic β-…”
BackgroundYoo, K., Ko, S., Park, J., Ahn, Y., Yim, H. W., Lee, W., & Park, Y. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04248.x · Cited by 28
Sharifi, F., Ziaee, V., Feizy, Mousavinasab, S. N. A. D., Anjomshoaa, & Mokhtari, M. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s15049 · Cited by 39
“Whether this association is independent of BMI is not clear.(1,2,14,17) Few data regarding the correlation of ferritin levels and body fat during pregnancy have been reported.”
Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes
Davis, T. M. E., Beilby, J. P., Davis, W. A., Olynyk, J. K., Jeffrey, G. P., Rossi, E., Boyder, C., & Bruce, D. G. (2008) · Diabetes Care · doi:10.2337/dc08-0248 · Cited by 27
“Hyperglycemia, and other effects of excess tissue iron including oxidant stress, angiogenesis and fibrosis (4-6), could promote the development of complications such as nephropathy (7,8).”
Serum Ferritin Levels Are Positively Associated With Metabolically Obese Normal Weight
Kim, J. W., Kim, D., Roh, Y. K., Ju, S.-Y., Nam, H.-Y., Nam, G. E., Kim, D.-W., Lee, S.-H., Lee, C.-W., Han, K., et al. (2015) · Medicine · doi:10.1097/md.0000000000002335 · Cited by 29
“hyperinsulinemia in the early phase of insulin resistance, and it inhibits the production of insulin as a more advanced phase is entered.(14,15) Iron acts as a catalyst for more reactive hydroxyl radicals and as an oxidative stress at multiple cellular targets.”
BackgroundKhan, F. A., Al‐Jameil, N., Arjumand, S., Khan, M. F., Tabassum, H., Alenzi, N., Hijazy, S. M., Alenzi, S., Subaie, S., & Fatima, S. (2015) · Biological Trace Element Research · doi:10.1007/s12011-015-0379-3 · Cited by 28
Li, J., Lange, L. A., Duan, Q., Lu, Y., Singleton, A., Zonderman, A. B., Evans, M. K., Li, Y., Taylor, H. A., Willis, M. S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu454 · Cited by 26
“Genetic factors could affect iron metabolism through gastrointestinal absorption, transport, tissue uptake, storage or remobilization from tissue stores, and thus could have a large impact on the variation of these iron-related measures (2,3).”
BackgroundSelf-citationAdipose Tissue Transferrin and Insulin Resistance
McClain, D. A., Sharma, N., Jain, S., HARRISON, A. V., Salaye, L., Comeau, M. E., Langefeld, C. D., Lorenzo, F., & Das, S. K. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00770 · Cited by 28
A Prospective Study of Magnesium and Iron Intake and Pancreatic Cancer in Men
Kesavan, Y., Giovannucci, E. L., Fuchs, C. S., & Michaud, D. S. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp373 · Cited by 26
“Iron may also be related to insulin resistance since direct iron deposition in b-cells in the pancreas can impair insulin secretion (50).”
BackgroundTelomere length and elevated iron: The influence of phenotype and HFE genotype
Mainous, A. G., Wright, R. U., Hulihan, M., Twal, W. O., McLaren, C. E., Díaz, V. A., McLaren, G. D., Argraves, W. S., & Grant, A. M. (2013) · American Journal of Hematology · doi:10.1002/ajh.23438 · Cited by 26
“These variables may be in the causal pathway between elevated iron and telomere length [37,53,54].”
Wang, Y., Koh, W., Yuan, J., & Pan, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.012 · Cited by 25
Korc, M. (2004) · Disease Markers · doi:10.1155/2004/945073 · Cited by 25
“It has been suggested that increased iron stores in general may lead to an increased propensity to T2DM [47], and that both chronic pancreatitis and pancreatic cancer may be associated with a significant”
Kaygusuz, İ., Gümüş, İ. İ., Yılmaz, S., Simavlı, S. A., Uysal, S., Derbent, A. U., Gözdemir, E., & Kafalı, H. C. (2013) · Gynecologic and Obstetric Investigation · doi:10.1159/000348560 · Cited by 25
Ahn, S. H., Lee, S., Kim, H., Lee, S. H., Kim, B., & Koh, J. (2016) · Endocrine Research · doi:10.3109/07435800.2016.1155600 · Cited by 23
“Iron is a catalyst for the formation of hydroxyl radicals, which are powerful oxidants that attack cellular membrane lipids, proteins, and nucleic acids, resulting in tissue damage (36,37) and contributing to the pathogenesis of various diseases, such as insulin resistance (38).”
BackgroundRelevance of the ability of fructose 1,6-bis(phosphate) to sequester ferrous but not ferric ions
Bajić, A., Zakrzewska, J., Gođevac, D. M., Anđjus, P. R., Jones, D. R., Spasić, M. B., & Spasojević, I. (2010) · Carbohydrate Research · doi:10.1016/j.carres.2010.12.008 · Cited by 23
Altunoğlu, E., Müderrisoğlu, C., Erdenen, F., Ülgen, E., & Ar, M. C. (2013) · Turkish Journal of Hematology · doi:10.4274/tjh.2012.0187 · Cited by 22
“In addition, iron is a potent pro-oxidant that increases cellular oxidative stress, causing inhibition of insulin internalization and action, which results in hyperinsulinemia, IR, and abnormal β-cell function through iron toxicity [16,20,21,22,23,24,25].”
BackgroundTiongco, R. E., Arceo, E. S., Clemente, B., & Pineda-Cortel, M. R. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4932-0 · Cited by 25
The relationship between serum ferritin and metabolic syndrome in healthy Korean men
Ryoo, J., Kim, M., Lee, D., & Shin, J. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1211 · Cited by 22
“Others have suggested that iron deposition in pancreatic β-cells may also impair insulin secretion in more advanced states of iron overload [21].”
BackgroundIkeda, Y., Suehiro, T., Yamanaka, S., Kumon, Y., Takata, H., Inada, S., Ogami, N., Osaki, F., Inoue, M., Arii, K., et al. (2006) · Endocrine Journal · doi:10.1507/endocrj.k06-010 · Cited by 22
“There are some reports suggesting a significant influence of tissue iron excess on the development of diabetic nephropathy and vascular dysfunction [22, 23].”
BackgroundJuanola‐Falgarona, M., Fernández‐Cao, J. C., Salas‐Salvadó, J., Martínez‐González, M. Á., Estruch, R., Fiol, M., Arija, V., Bulló, M., & for the PREDIMED Study Investigators (2013) · PLoS ONE · doi:10.1371/journal.pone.0076433 · Cited by 21
“Iron deposition in the muscle decreases glucose uptake due to muscle damage [18] and it has additionally been suggested that iron deposition in pancreatic b-cells impairs insulin secretion in more advanced states of iron overload [19].”
BackgroundMitochondrial response to oxidative and nitrosative stress in early stages of diabetes
Noriega‐Cisneros, R., Cortés‐Rojo, C., Manzo‐Ávalos, S., Clemente‐Guerrero, M., Calderón‐Cortés, E., Salgado‐Garciglia, R., Montoya-Pérez, R. D. C., Boldogh, I. R., & Saavedra‐Molina, A. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.05.012 · Cited by 21
“It has been suggested that this phenomenon may be implicated in the development of diabetes (Kell, 2009; Wilson et al., 2003).”
BackgroundLi, B., Lin, W. G., Lin, N., Dong, X., & Liu, L. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1668 · Cited by 21
“association between iron protein and inflammation has been confirmed by many studies and numerous scholars consider that ferritin may be an inflammatory factor (5,9,14,15).”
BackgroundInfluentialAdams, P. C. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.06.002 · Cited by 20
Guo, W., Zhou, Q., Jia, Y., & Xu, J. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01747-x · Cited by 21
Metadata
- Authors
- Wilson, J. G., Maher, J. F., Lindquist, J. H., Grambow, S. C., & Crook, E. D.
- Affiliations
- University of Mississippi Medical Center (US)
- Durham VA Medical Center (US)
- Duke Medical Center (US)
- Wayne State University (US)
- Corresponding author
- Wilson, James G.
- Venue
- The American Journal of the Medical Sciences
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 325
- Issue
- 6
- Pages
- 332-339
- ISSN
- 0002-9629 (ISSN-L)
- OpenAlex
- W2015938505
- Cited by
- 176
- References
- 63
- Citations by year
- 2025: 4 · 2024: 6 · 2023: 5 · 2022: 2 · 2021: 7 · 2020: 4 · 2019: 5 · 2018: 7 · 2017: 6 · 2016: 10 · 2015: 12 · 2014: 15 · 2013: 17 · 2012: 9
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of the Medical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- diabetes mellitus, iron overload, serum ferritin, hereditary hemochromatosis, transfusional iron overload, secondary diabetes, African Americans, cardiovascular risk, glucose tolerance, HbA1c
- MeSH terms
- Animals, Black or African American, Clinical Trials as Topic, Diabetes Mellitus, Humans, Iron, Iron Overload, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review